Tempest Therapeutics, Inc. Prepaid Expense and Other Assets, Current
Tempest Therapeutics, Inc. (TPST) had Prepaid Expense and Other Assets, Current of $918.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-13
- 2026-06-30: Prepaid Expense and Other Assets, Current $918.00K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $641.00K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $562.00K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $590.00K.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $918.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $641.00K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $562.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $590.00K 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $823.00K 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $922.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $1.21M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $1.44M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $424.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $1.17M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $1.13M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $1.17M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $931.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $1.30M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $1.27M 10-K · filed 2024-03-19 | |
| 2022-09-30 | $2.27M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $1.69M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $1.96M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $2.13M 10-K · filed 2023-03-22 | |
| 2021-09-30 | $2.80M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $2.04M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $2.13M 10-Q · filed 2022-05-13 | $1.81M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $1.00M 10-K · filed 2022-03-29 | $1.93M 10-K · filed 2021-03-29 |
| 2020-09-30 | $1.00M 10-Q · filed 2021-11-10 | $2.09M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $2.85M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $4.21M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $6.34M 10-K · filed 2021-03-29 | |
| 2019-09-30 | $4.48M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $6.42M 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $4.17M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $3.37M 10-K · filed 2020-03-11 | |
| 2018-09-30 | $1.85M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $547.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $835.00K 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $1.08M 10-K · filed 2019-04-01 | $1.58M 10-K · filed 2018-03-15 |
| 2017-09-30 | $1.87M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $2.54M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $2.05M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $2.06M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $2.46M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $2.46M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $2.54M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $3.00M 10-K · filed 2017-03-02 | |
| 2015-09-30 | $3.54M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $3.43M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $1.89M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $1.65M 10-K · filed 2016-02-26 | |
| 2014-09-30 | $1.45M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $1.25M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $605.00K 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $650.00K 10-K · filed 2015-03-16 | |
| 2013-09-30 | $841.00K 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $917.00K 10-Q · filed 2013-08-13 | |
| 2013-03-31 | $481.00K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $574.00K 10-K · filed 2014-02-27 | |
| 2012-09-30 | $460.00K 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $209.00K 10-Q · filed 2012-08-14 | |
| 2011-12-31 | $44.00K 10-K · filed 2013-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |